Our Team

• Pfizer
  • in the Federal Court of Appeal in proceedings pursuant to the Patented Medicines (Notice of Compliance) Regulations versus Novopharm related to celecoxib (Celebrex®)
  • in the Federal Court and Federal Court of Appeal in proceedings pursuant to the Patented Medicines (Notice of Compliance) Regulations versus ratiopharm, Apotex, Cobalt and Pharmascience related to amlodipine besylate (Norvasc®)
  • in the Federal Court in proceedings pursuant to the Patented Medicines (Notice of Compliance) Regulations versus Mayne Pharma related to epirubicin hydrochloride (Pharmorubicin®)
• Canadian and North American pharmaceutical and biologics companies involved in patent litigation and proceedings pursuant to the Patented Medicines (Notice of Compliance) Regulations
• a North American pharmaceutical and biologics company in various matters involving licensing disputes and the Patented Medicine Prices Review Board
• a Canadian pharmaceutical company in the settlement of a multijurisdictional patent proceeding
• a leading North American pressure-sensitive tapes manufacturer in trademark infringement proceedings
• a leading cosmetic company in various matters concerning trademark infringement and passing off
• a leading Canadian consumer goods company in various matters involving trademark enforcement
• a global integrated information solutions company in a complex trademark opposition proceeding

Kamleh is actively involved in continuing legal education for the Canadian Bar Association’s National Intellectual Property Section.

Before joining Torys, Kamleh was a partner at a Toronto intellectual property boutique, where her practice was focused on pharmaceutical patent litigation and trademark litigation.

CLE Committee, National IP Section, Canadian Bar Association (chair)
International Trademark Association
Intellectual Property Institute of Canada
Intellectual Property Section, American Bar Association
The Advocates’ Society